Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Invesco S&P 500 Revenue ETF
RWL
|
$658M |
| 2 |
Tesla
TSLA
|
$573M |
| 3 |
Bank of America
BAC
|
$480M |
| 4 |
Amazon
AMZN
|
$448M |
| 5 |
Canadian Pacific Kansas City
CP
|
$445M |
Top Sells
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
$493M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$395M |
| 3 |
Eli Lilly
LLY
|
$364M |
| 4 |
CME Group
CME
|
$316M |
| 5 |
T-Mobile US
TMUS
|
$310M |
Sector Composition
| 1 | Technology | 23.42% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3601
AirSculpt Technologies
AIRS
$367M
| $56.4K | ﹤0.01% |
+24,169
| New | +$56.4K |
|
3602
Caribou Biosciences
CRBU
$174M
| $53.8K | ﹤0.01% |
58,974
-6,721
| -10% | -$6.14K |
|
3603
AbCellera Biologics
ABCL
$1.26B
| $53.8K | ﹤0.01% |
24,146
+12,893
| +115% | +$28.8K |
|
|
IAUX
3604
i-80 Gold Corp
IAUX
$694M
| $53.7K | ﹤0.01% |
92,274
-878
| -0.9% | -$511 |
|
3605
Rimini Street
RMNI
$416M
| $52.4K | ﹤0.01% |
15,049
-491
| -3% | -$1.71K |
|
3606
Cadiz
CDZI
$291M
| $52.1K | ﹤0.01% |
17,794
-634
| -3% | -$1.86K |
|
|
RGLS
3607
DELISTED
Regulus Therapeutics
RGLS
| $51.6K | ﹤0.01% |
29,460
-788
| -3% | -$1.38K |
|
3608
Humacyte
HUMA
$226M
| $51.4K | ﹤0.01% |
30,145
-782
| -3% | -$1.33K |
|
3609
Riskified
RSKD
$726M
| $50.8K | ﹤0.01% |
+10,994
| New | +$50.8K |
|
|
AUTL
3610
Autolus Therapeutics
AUTL
$389M
| $50.7K | ﹤0.01% |
32,738
+11,381
| +53% | +$17.6K |
|
|
MODV
3611
DELISTED
ModivCare
MODV
| $50.1K | ﹤0.01% |
38,104
-9,520
| -20% | -$12.5K |
|
3612
Personalis
PSNL
$465M
| $48.7K | ﹤0.01% |
13,869
-321
| -2% | -$1.13K |
|
3613
Perspective Therapeutics
CATX
$257M
| $48.4K | ﹤0.01% |
22,742
-2,432
| -10% | -$5.18K |
|
3614
Sera Prognostics
SERA
$127M
| $48.3K | ﹤0.01% |
13,124
-584
| -4% | -$2.15K |
|
3615
Dakota Gold
DC
$499M
| $48.1K | ﹤0.01% |
18,150
+230
| +1% | +$609 |
|
3616
Gossamer Bio
GOSS
$668M
| $48.1K | ﹤0.01% |
+43,697
| New | +$48.1K |
|
3617
ALX Oncology
ALXO
$65.3M
| $46K | ﹤0.01% |
+73,836
| New | +$46K |
|
3618
Stereotaxis
STXS
$264M
| $45.8K | ﹤0.01% |
26,025
-971
| -4% | -$1.71K |
|
3619
Eve Holding
EVEX
$1.18B
| $45.8K | ﹤0.01% |
13,789
+2,344
| +20% | +$7.78K |
|
3620
WM Technology
MAPS
$126M
| $44.9K | ﹤0.01% |
39,769
-1,688
| -4% | -$1.91K |
|
3621
Design Therapeutics
DSGN
$367M
| $43.7K | ﹤0.01% |
11,331
-252
| -2% | -$973 |
|
3622
loanDepot
LDI
$605M
| $43.5K | ﹤0.01% |
+36,576
| New | +$43.5K |
|
3623
Wheels Up
UP
$1.4B
| $42.9K | ﹤0.01% |
42,470
-2,072
| -5% | -$2.09K |
|
|
JQC.RT
3624
DELISTED
Nuveen Credit Strategies Income Fund Rights (expiring April 29, 2025)
JQC.RT
| $42.4K | ﹤0.01% |
+1,412,229
| New | +$42.4K |
|
|
IGMS
3625
DELISTED
IGM Biosciences
IGMS
| $41.5K | ﹤0.01% |
+36,127
| New | +$41.5K |
|